The FDA approved 3 new color additives, a move that will provide manufacturers with a wider range of natural color options to safely be used in food.

A Cornell University project to save babies born with serious heart defects has lost key funding just days after it was approved.

The FDA has approved HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood pressure.

Survival outcomes have improved since 2014 among young, competitive athletes with SCA, although these improvements are mostly among White patients.

A study has found that use of the Organ Care System for heart donation after brain death has favorable post-transplantation outcomes.

The head of the FDA reiterated that the agency is applying a more skeptical approach to this year’s round of COVID-19 vaccine boosters.

President Donald Trump has chosen Dr Casey Means, a wellness influencer and health tech entrepreneur, to be his nominee for surgeon general.

The FDA has approved the SAPIEN 3 platform, a TAVR therapy, for patients with severe aortic stenosis without symptoms.

Over a 10-year period, METS-IR effectively predicted CV events among patients with PsA, with values greater than 2.48 at baseline conferring the greatest risk.

No significant association was observed between viremia history during ART and CVD risk in a large international cohort of patients with HIV infection.

Men with gout and obesity receiving febuxostat-based ULT were less likely to achieve SU targets and more frequently experienced disease flares.

Decreases in global cognition and executive function, as well as long-term persistent declines in those cognitive domains, are associated with incident HF.